| Company Information |
| Address: |
Mitre House 160 Aldersgate Street London EC1A 4DD
|
Index: |
FTSE Fledgling FTSE TechMark Focus FTSE TechMark All Share FTSE TechMark Mediscience
|
| Tel: |
+44(0) 207 099 7268
|
Sector: |
Pharmaceuticals
|
| Fax: |
|
|
|
| E-Mail: |
info@antisoma.com |
Epic: |
ASM |
| Secretary: |
Christopher Hill |
|
|
| Registrar: |
Neville Registrars Ltd
|
Updated: |
8/05/2013 |
Company Overview
The principal activity of the Company is the investment in and growth and development of businesses which present opportunities for value creation.
The Directors of Antisoma intend to identify investment opportunities offering the potential to deliver a favourable return to shareholders over the medium term, primarily in the form of a capital gain. A particular consideration will be to identify businesses which, in the opinion of the Directors, are under-performing and present opportunities for value creation. The Company's equity interest in a potential investment may range from a minority position to 100 per cent. ownership and the interest may be either quoted or unquoted.
|